🇺🇸 FDA

P0 · Therapeutic area intelligence

Infectious disease patent intelligence

Antiviral, antibacterial, and vaccine-related pharmaceutical patents.

Patents
1,469

Quick answer

1,469 US pharmaceutical patents in our index match Infectious disease title keywords (A61K/A61P). Cross-link to related drug therapeutic-area hubs and company patent portfolios for full IP context.

  1. US 6989370

    Bacteriocins and novel bacterial strains

    The United States of America, as represented by the Secretary of Agriculture · Granted Tue Jan 24 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 19 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  2. US 6987166

    Compositions and methods for the treatment of sepsis

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Jan 17 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 12 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  3. US 6987096

    Antiviral proteins and peptides, DNA coding sequences therefor, and uses thereof

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jan 17 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 12 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  4. US 6984622

    Use of lipopolysaccharides to manage corneal infections and wounds

    The Regents of the University of California · Granted Tue Jan 10 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 05 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  5. US 6984381

    Vaccine for the prevention of bacterial infection of the bovine mammary gland

    The United States of America, as represented by the Secretary of Agriculture · Granted Tue Jan 10 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 05 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  6. US 6979451

    Recombinant antigen MSP1a from anaplasma marginale to reduce infections in ticks, vaccine compositions and methods of use

    The Board of Regents for Oklahoma State University · Granted Tue Dec 27 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 22 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  7. US 6974580

    Mycobacterial sulfation pathway proteins and methods of use thereof

    The Regents of the University of California · Granted Tue Dec 13 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 08 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  8. US 6958345

    2-hydroxymethylcyclopropylidene methylpurines and -pyrimidines as antiviral agents

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Oct 25 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 20 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  9. US 6953575

    Methods of treating central nervous system disorders using viral vectors

    The Regents of the University of California · Granted Tue Oct 11 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 06 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  10. US 6951847

    Methods of treating fungal infections using lupeol

    Regents of the University of Minnesota · Granted Tue Oct 04 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 29 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  11. US 6951219

    Treatment of hepatitis C using hyperthermia

    First Circle Medical, Inc. · Granted Tue Oct 04 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 29 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  12. US 6942855

    Viral vectors having reduced virulence

    THE ARIZONA BOARD OF REGENTS · Granted Tue Sep 13 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 08 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  13. US 6943175

    2-NH-heteroarylimidazoles with antibacterial activity

    Replidyne, Inc. · Granted Tue Sep 13 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 08 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  14. US 6942986

    Compositions and methods for regulating bacterial pathogenesis

    THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Tue Sep 13 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 08 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  15. US 6936435

    Compositions and methods for regulating bacterial pathogenesis

    THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Tue Aug 30 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 25 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  16. US 6930176

    Major neutralization site of hepatitis E virus and use of this neutralization site in methods of vaccination and in methods of screening for neutralizing antibodies to hepatitis E virus

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Aug 16 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 11 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  17. US 6924362

    Monoclonal antibodies specific for the E2 glycoprotein of hepatitic C virus and their use in the diagnosis, treatment, and prevention of hepatitis C

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Aug 02 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 28 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  18. US 6923973

    Peptide and DNA immunization against Coccidioides immitis infections

    The Board of Regents of the University of Texas System · Granted Tue Aug 02 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 28 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  19. US 6913757

    Live, avirulent strain of V. anguillarum that protects fish against infection by virulent V. anguillarum and method of making the same

    Board of Governors for Higher Education, State of Rhode Island and Providence Plantations · Granted Tue Jul 05 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 30 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  20. US 6911527

    HIV related peptides

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Jun 28 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 23 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  21. US 6905680

    Methods of treating HIV infected subjects

    United States of America as represented by the Secretary of the Air Force · Granted Tue Jun 14 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 09 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  22. US 6902743

    Therapeutic treatment and prevention of infections with a bioactive material(s) encapuslated within a biodegradable-bio-compatable polymeric matrix

    The United States of America as represented by the Secretary of the Army · Granted Tue Jun 07 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 02 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  23. US 6899880

    Porin B (PorB) as a therapeutic target for prevention and treatment of infection by chlamydia

    The Regents of the University of California · Granted Tue May 31 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 26 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  24. US 6872398

    Conjugate vaccine against gram-negative bacterial infections

    The United States of America as represented by the Secretary of the Army · Granted Tue Mar 29 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 24 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  25. US 6869602

    Method for treating, preventing, or inhibiting enterotoxigenic Escherichia coli infections with bovine red blood cells

    The United States of America as represented by the Secretary of the Army · Granted Tue Mar 22 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 17 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  26. US 6869925

    Inhibition of retrovirus infection

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Mar 22 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 17 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  27. US 6869924

    Human derived monocyte attracting purified protein product useful in a method of treating infection and neoplasms in a human body, and the cloning of full length cDNA thereof

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Mar 22 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 17 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  28. US 6866845

    Compositions and methods for the treatment of sepsis

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Mar 15 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 10 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  29. US 6864067

    Compositions and methods for regulating bacterial pathogenesis

    THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Tue Mar 08 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 03 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  30. US 6863895

    Mycobacterial sulfation pathway proteins and methods of use thereof

    The Regents of the University of California · Granted Tue Mar 08 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 03 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  31. US 6858211

    Vaccines against Escherichia coli O157 infection

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Feb 22 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 17 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  32. US 6852324

    Immunization for ebola virus infection

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Feb 08 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 03 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  33. US 6849429

    Viral pseudo-capsids including assembly agonists and antagonists

    The Board of Regents of the University of Texas System · Granted Tue Feb 01 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 27 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  34. US 6849605

    Inhibitors of serine protease activity, methods and compositions for treatment of viral infections

    The Regents of the University of Technology Office of Technology Transfer · Granted Tue Feb 01 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 27 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  35. US 6849610

    Polynucleotide ligands as anti-viral agents

    The Regents of the University of California · Granted Tue Feb 01 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 27 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  36. US 6846652

    Viral vectors having enhanced effectiveness with reduced virulence

    THE ARIZONA BOARD OF REGENTS · Granted Tue Jan 25 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 20 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  37. US 6844423

    Compositions and methods for regulating bacterial pathogenesis

    THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Tue Jan 18 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 13 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  38. US 6844010

    Therapeutic treatment and prevention of infections with a bioactive materials encapsulated within a biodegradable-biocompatible polymeric matrix

    The United States of America as represented by the Secretary of the Army · Granted Tue Jan 18 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 13 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  39. US 6841661

    Glycopeptide antibacterial compounds, compositions containing same and methods of using same

    THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Tue Jan 11 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 06 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  40. US 6838237

    Antigenically reactive regions of the hepatitis a virus polyprotein

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jan 04 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 30 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  41. US 6828416

    Recombinant multivalent malarial vaccine against Plasmodium falciparum

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Dec 07 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 02 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  42. US 6824976

    Method for selective inactivation of viral replication

    Rigel Pharmaceuticals, Inc. · Granted Tue Nov 30 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 25 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  43. US 6824769

    Optimal compositions and methods thereof for treating HCV infections

    Vertex Pharmaceuticals Incorporated · Granted Tue Nov 30 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 25 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  44. US 6811780

    Methods of using cytokine antagonists to treat HIV infection and AIDS

    REGENERON PHARMACEUTICALS, INC. · Granted Tue Nov 02 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 28 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  45. US 6808877

    Ligands for FPR class receptors that induce a host immune response to a pathogen or inhibit HIV infection

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Oct 26 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 21 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  46. US 6794174

    Full-length infectious cDNA clones of tick borne flavivirus

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Sep 21 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 16 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  47. US 6790449

    Methods for producing self-replicating infectious RSV particles comprising recombinant RSV genomes or antigenomes and the N, P, L, and M2 proteins

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Sep 14 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 09 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  48. US 6790841

    2-hydroxymethylcyclopropylidenemethylpurines and -pyrimidines as antiviral agents

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Sep 14 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 09 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

Frequently asked questions

How many Infectious disease patents are indexed?

1,469 patents match our Infectious disease classifier (title keywords in USPTO records).

Is this legal or medical advice?

No — patent intelligence is for professional reference. Verify expiration and FTO with qualified patent counsel and primary USPTO records.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.